FDA 483 - Alembic Pharmaceuticals Limited - March 24, 2023

Alembic Pharmaceuticals Limited in Vadodara, India, a sterile drug manufacturer, received a Form 483 with two observations. The inspection revealed inadequate quality control unit oversight regarding batch record review for drug product release and deficiencies in the internal audit system. These issues indicate a lack of robust quality management practices.